By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Kangji Medical Holdings Limited

Kangji Medical Holdings Limited (9997.HK)

HKSE Market Data in HKD, Fundamentals in CNY
$8.63
-$0.05
-0.58%
Last Update: 1 Sept 2025, 03:36
$10.17B
Market Cap
0.00
P/E Ratio (TTM)
3.03%
Forward Dividend Yield
$4.91 - $8.89
52 Week Range

9997.HK Stock Price Chart

Explore Kangji Medical Holdings Limited interactive price chart. Choose custom timeframes to analyze 9997.HK price movements and trends.

9997.HK Company Profile

Discover essential business fundamentals and corporate details for Kangji Medical Holdings Limited (9997.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

IPO Date

29 Jun 2020

Employees

1.01K

CEO

Ming Zhong

Description

Kangji Medical Holdings Limited, through its subsidiaries, designs, develops, manufactures, and sale of minimally invasive surgical instruments and accessories in China. It offers disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, ultrasonic scalpels, and other types of disposable hand-held instruments; and reusable trocars, reusable forceps, and other reusable products. The company's products are used in obstetrics and gynecology, general surgery, urology, and thoracic surgery specialties. It primarily sells products to a network of distributors. The company was founded in 2004 and is headquartered in Hangzhou, China.

9997.HK Financial Timeline

Browse a chronological timeline of Kangji Medical Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 23 Mar 2026

Earnings released on 28 Aug 2025

EPS came in at $0.25 falling short of the estimated $0.26 by -6.01%, while revenue for the quarter reached $544.12M , beating expectations by +1.60%.

Dividend declared on 27 May 2025

A dividend of $0.26 per share was announced, adjusted to $0.26. The dividend was paid on 16 Jul 2025.

Earnings released on 24 Mar 2025

EPS came in at $0.27 surpassing the estimated $0.27 by +0.19%, while revenue for the quarter reached $585.30M , missing expectations by -2.27%.

Earnings released on 21 Aug 2024

EPS came in at $0.26 falling short of the estimated $0.27 by -2.46%, while revenue for the quarter reached $492.29M , beating expectations by +0.41%.

Dividend declared on 29 May 2024

A dividend of $1.54 per share was announced, adjusted to $1.54. The dividend was paid on 18 Jul 2024.

Earnings released on 21 Mar 2024

EPS came in at $0.24 falling short of the estimated $0.27 by -11.48%, while revenue for the quarter reached $578.23M , missing expectations by -53.50%.

Earnings released on 29 Aug 2023

EPS came in at $0.24 surpassing the estimated $0.18 by +32.77%, while revenue for the quarter reached $436.45M , beating expectations by +2.36%.

Dividend declared on 30 May 2023

A dividend of $0.20 per share was announced, adjusted to $0.20. The dividend was paid on 10 Jul 2023.

Earnings released on 28 Mar 2023

EPS came in at $0.31 surpassing the estimated $0.18 by +73.76%, while revenue for the quarter reached $517.12M , missing expectations by -54.04%.

Earnings released on 25 Aug 2022

EPS came in at $0.15 falling short of the estimated $0.16 by -6.19%, while revenue for the quarter reached $389.04M , missing expectations by -0.15%.

Dividend declared on 27 May 2022

A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 8 Jul 2022.

Earnings released on 22 Mar 2022

EPS came in at $0.26 surpassing the estimated $0.20 by +27.50%, while revenue for the quarter reached $455.63M , missing expectations by -5.24%.

Earnings released on 26 Aug 2021

EPS came in at $0.19 surpassing the estimated $0.16 by +24.63%, while revenue for the quarter reached $381.95M , beating expectations by +0.33%.

Dividend declared on 28 May 2021

A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 29 Jun 2021.

Earnings released on 25 Mar 2021

EPS came in at $0.16 falling short of the estimated $0.19 by -16.68%, while revenue for the quarter reached $354.98M , missing expectations by -23.44%.

9997.HK Stock Performance

Access detailed 9997.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run